AMINOSOL 5% Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Aminosol 5%, and when can generic versions of Aminosol 5% launch?
Aminosol 5% is a drug marketed by Abbvie and is included in one NDA.
The generic ingredient in AMINOSOL 5% is protein hydrolysate. There are thirty-eight drug master file entries for this compound. Additional details are available on the protein hydrolysate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for AMINOSOL 5%?
- What are the global sales for AMINOSOL 5%?
- What is Average Wholesale Price for AMINOSOL 5%?
Summary for AMINOSOL 5%
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
DailyMed Link: | AMINOSOL 5% at DailyMed |
US Patents and Regulatory Information for AMINOSOL 5%
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Abbvie | AMINOSOL 5% | protein hydrolysate | INJECTABLE;INJECTION | 005932-012 | Jan 31, 1985 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |